Chung et al. [67] further reported that synergistic effects of SN-38 with metformin enhance antitumor immunity by facilitating the infiltration of NK and CD8+ T cells into the TME, leading to increased secretion of interferon-γ and granzyme B, critical mediators of tumor cell killing. The gene discussed is CD8A; the disease is neoplasm.